Gastric Volvulus Treatment Global Market Report 2024 - By Trends, Share, Growth, Report, Outlook By 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Gastric Volvulus Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $34.63 billion In 2028 At A CAGR Of 6.2%.
The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $25.6 billion in 2023 to $27.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research and clinical studies.

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $34.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, adoption of advanced imaging techniques.. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, customized treatment approaches.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Gastric Volvulus Treatment Market Major Segments
The gastric volvulus treatment market covered in this report is segmented -
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Key Driver - Growing Geriatric Demographics Fueling Advancements In The Gastric Volvulus Treatment Market
A rising geriatric population is expected to propel the growth of the gastric volvulus treatment market going forward. The geriatric population refers to older adults 65 years and beyond. The geriatric population suffers from various diseases due to low immunity and age. Gastric volvulus occurs in older adults over the age of 50, hence, the rise in the geriatric population is expected to propel the market. For instance, in November 2022, according to America's Health Rankings, a US-based partnership between the United Health Foundation and the American Public Health Association, in 2021, more than 55.8 million people aged 65 and above were present in the United States, accounting for nearly 16.8% of the total population. Therefore, rising geriatric populations are driving the gastric volvulus treatment market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=9382&type=smp

Prominent Trend - Product Innovation In Gastric Volvulus Treatment Market
Product innovations are a key trend gaining popularity in the gastric volvulus treatment market. Major companies operating in the market are introducing innovative products to sustain their position in the gastric volvulus treatment market. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for people with moderate to severe active ulcerative colitis (UC). VELSIPITY's official suggested dosage is 2 mg. ELSIPITY allows adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that has a positive benefit-risk profile. The FDA's approval of VELSIPITY today marks an important turning point for UC patients who require novel therapies for this long-term illness and are ready to begin advanced therapy.

Gastric Volvulus Treatment Market Players
Major companies operating in the gastric volvulus treatment market report are PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, Mylan N.V., GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc, ACROBiosystems Inc., Alomone Labs Ltd. .

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the gastric volvulus market in 2023. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Gastric Volvulus Treatment Market Report Structure
3. Gastric Volvulus Treatment Market Trends And Strategies
4. Gastric Volvulus Treatment Market - Macro Economic Scenario
5. Gastric Volvulus Treatment Market Size And Growth
…..
27. Gastric Volvulus Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.